✦ LIBER ✦

IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients

✍ Scribed by Aharon Kessel; Regina Peri; Tharwat Haj; Ayelet Snir; Gleb Slobodin; Edmond Sabo; Itzhak Rosner; Yehuda Shoenfeld; Elias Toubi

Publisher: Springer
Year: 2010
Tongue: English
Weight: 266 KB
Volume: 31
Category: Article
ISSN: 0271-9142
DOI: 10.1007/s10875-010-9469-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Functional TLR9 modulates bone marrow B

Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients

✍ Weronika Rudnicka; Tomasz Burakowski; Ewa Warnawin; Magdalena Jastrzebska; Magda 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB

TLR-9 Activation of Marginal Zone B Cell

TLR-9 Activation of Marginal Zone B Cells in Lupus Mice Regulates Immunity Through Increased IL-10 Production

✍ PETAR LENERT; RACHEL BRUMMEL; Elizabeth H. Field; ROBERT F. ASHMAN 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 935 KB

Activation via the antigen receptor is i

Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency

✍ Michael B. Fischer; Hermann M. Wolf; Ilona Hauber; Heinz Eggenbauer; Vojtech Tho 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

Activation of NF-κB in intestinal epithe

Activation of NF-κB in intestinal epithelial cells byE. colistrains isolated from the colonic mucosa of IBD patients

✍ Katia La Ferla; Dirk Seegert; Stefan Schreiber 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 337 KB

Normal CD40-mediated activation of monoc

Normal CD40-mediated activation of monocytes and dendritic cells from patients with hyper-IgM syndrome due to a CD40 pathway defect in B cells

✍ Patrick Revy; Frédéric Geissmann; Marianne Debré; Alain Fischer; Anne Durandy 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Participation of factor B in residual im

Participation of factor B in residual immune complex red cell binding activity observed in serum from a C2-deficient systemic lupus erythematosus patient may delay the appearance of clinical symptoms

✍ Kristin H. Traustadóttir; Bjarni O. Rafnar; Kristján Steinsson; Helgi Valdimarss 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

Objective. To investigate whether participation of factor B (FB) in immune complex transport might explain long periods of clinical remissions in a homozygous C2-deficient patient with systemic lupus erythematosus (SLE) treated regularly with plasma infusions. Methods. Immune complex red cell bindi